Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.
Endotoxin release from Pseudomonas aeruginosa treated with cell wall-active carbapenem antibiotics and its effect on the production of tumor necrosis factor alpha and nitric oxide were examined. Treatment of bacteria with imipenem induced much lower levels of endotoxin release than treatment with meropenem. The endotoxin released was demonstrated to be of the smooth type and O-specific polysaccharide-rich. The exposure of the filtrates of P. aeruginosa treated with imipenem to physiologically relevant cells caused low-level production of tumor necrosis factor alpha and nitric oxide, while similar treatment with meropenem induced high levels of production.
Yokochi
T
T
Department of Microbiology and Immunology, Aichi Medical University, Japan. yokochi@amugw.aichi-med-u.ac.jp
Kusumi
A
A
Kido
N
N
Kato
Y
Y
Sugiyama
T
T
Koide
N
N
Jiang
G Z
GZ
Narita
K
K
Takahashi
K
K
D015780:Carbapenems / Q000494:pharmacology*; D002442:Ceftazidime / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D004731:Endotoxins / Q000096:biosynthesis*; D015378:Imipenem / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000096:biosynthesis*; D008233:Lymphotoxin-alpha / Q000096:biosynthesis*; D000077731:Meropenem; D009569:Nitric Oxide / Q000378:metabolism; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000378:metabolism*; D013845:Thienamycins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D015780:Carbapenems; D002511:Cephalosporins; D004731:Endotoxins; D008070:Lipopolysaccharides; D008233:Lymphotoxin-alpha; D013845:Thienamycins; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide; D015378:Imipenem; D002442:Ceftazidime; D000077731:Meropenem